TACROLIMUS OINTMENT FOR TREATMENT OF VKC

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 43

Abstract

BACKGROUND Vernal Keratoconjunctivitis (VKC) is a bilateral recurrent chronic allergy inflammatory disorder of ocular surface, which is seasonally exacerbated mostly involving tarsal and bulbar conjunctiva in chronic and severe cases involves cornea as well. Affects mostly children and young adults with male predominance. Tacrolimus (FK-506) is a highly potent immune modulatory agent produced by the fungus Streptomyces tsukubaensis. MATERIALS AND METHODS This prospective, nonrandomised case series enrolled 20 patients (40 eyes) with severe VKC who were treated with tacrolimus 0.1% ointment. The mean age of the patients was 18.25 ± 4.2 years (range, 9-31 years). Each patient completed a follow-up period of at least 12 months. The main outcome measure was the clinical response to treatment. RESULTS Significant improvements in clinical signs and symptoms were achieved in all patients 6 weeks after starting treatment with topical tacrolimus. Treatment was gradually reduced with increasing intervals between applications. VKC recurred in all patients who attempted to discontinue treatment. No additional medications were required and no significant changes in visual acuity or refraction were documented. Five patients discontinued treatment due to a severe burning sensation and were excluded from the study. CONCLUSION Tacrolimus 0.1% ointment is a safe and effective treatment for VKC refractory to standard treatment and maybe used as a substitute for steroid treatments used to controlled-disease activity. However, adverse effects could cause poor patient compliance.

Authors and Affiliations

Navin Chandra, Suresh Kumar Sinha

Keywords

Related Articles

PREVALENCE OF VITAMIN D DEFICIENCY AND THE IMPACT OF ORAL SUPPLEMENTATION IN AN UNSELECTED PREGNANT INDIAN POPULATION

BACKGROUND There are many previous studies on vitamin D deficiency (VDD), providing evidence of widespread VDD in south Asian populations. It underscores the need for vitamin D supplementation and fortification guideline...

A PROSPECTIVE STUDY OF CHOLESTEATOMA IN PAEDIATRIC AGE GROUP AND ITS MANAGEMENT

INTRODUCTION A cholesteatoma (sometimes called a keratoma) is an abnormal growth of squamous epithelium in the middle ear and mastoid.1 It may progressively enlarge to surround and destroy the ossicles, resulting in cond...

SEXUAL DIMORPHISM IN PLANTAR DERMATOGLYPHICS

Dermatoglyphic study of fingertip and palmar patterns had been done extensively in various genetic and metabolic diseases. It appears that plantar dermatoglyphics has been neglected. So the present study is undertaken to...

A COMPARATIVE STUDY OF PRIMARY AND SECONDARY CLOSURE OF SURGICAL WOUNDS AFTER REMOVAL OF IMPACTED MANDIBULAR MOLAR

BACKGROUND Study was performed to compare primary and secondary closure of surgical wound after surgical removal of third molar. Conflicting opinion has been expressed in the literature. MATERIALS AND METHODS This study...

CONGENITAL CYSTIC ADENOMATOID MALFORMATION OF LUNG: A CASE REPORT

Congenital cystic adenomatoid malformation (CCAM) is a rare developmental abnormality of the lung previously termed as 'benign hamartoma' or 'dysplastic lung tumor'. It is characterized by abnormal proliferation of tissu...

Download PDF file
  • EP ID EP219929
  • DOI 10.18410/jebmh/2017/525
  • Views 98
  • Downloads 0

How To Cite

Navin Chandra, Suresh Kumar Sinha (2017). TACROLIMUS OINTMENT FOR TREATMENT OF VKC. Journal of Evidence Based Medicine and Healthcare, 4(43), 2649-2651. https://europub.co.uk/articles/-A-219929